ADP-Ribosylation Factor-Like 17B (ARL17) (Middle Region) Peptide
Quick Overview for ADP-Ribosylation Factor-Like 17B (ARL17) (Middle Region) Peptide (ABIN8094236)
Target
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- ARL17 Peptide - middle region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-ARL17 antibody ( ARP56258_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ARL17 (ADP-Ribosylation Factor-Like 17B (ARL17))
-
Background
-
Background Information: ARL17 is a GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. ARL17 is involved in protein trafficking, may modulate vesicle budding and uncoating within the Golgi apparatus.
Alternative Symbols: ARL17B, ARL17, ARL17A
-
Molecular Weight
- 19kDa
-
Gene ID
- 641522
-
NCBI Accession
- NP_001034172
-
UniProt
- Q8IVW1
Target
-